Stock listing
A1C821 Stock Price, News, Filings & Events — Mayne Pharma Group Ltd.
Selected listing: A1C821 · LSX · EUR · DE
This page tracks Mayne Pharma Group Ltd.'s A1C821:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1C821:LSX. A1C821:LSX is the stock-level entry point for investors researching Mayne Pharma Group Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A1C821:LSX
- Asset type
- Stock
- Market cap
- $183.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Mayne Pharma Group Ltd. A1C821:LSX stock context
This page tracks Mayne Pharma Group Ltd.'s A1C821:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1C821:LSX. A1C821:LSX is the stock-level entry point for investors researching Mayne Pharma Group Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Mayne Pharma Group Ltd.
2026 Full Year Results Media Release
August 26, 2026
Mayne Pharma reports unaudited Q4 and FY26 results
July 30, 2026
Mayne Pharma receives $14.4m for legal costs from Cosette
June 4, 2026
Court awards MYX $13.27m for legal costs from Cosette
May 21, 2026
Mayne Pharma reports unaudited 3Q FY26 results
April 28, 2026
Mayne Pharma Group Ltd. earnings calls
Research Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. investor report
Review AI stock analysis and investor report context for A1C821:LSX.
Mayne Pharma Group Ltd. company profile
View the public company page for Mayne Pharma Group Ltd. on 6ix.
Mayne Pharma Group Ltd. news
Read company news and market updates connected to Mayne Pharma Group Ltd..
Mayne Pharma Group Ltd. investor events
Find investor webinars, events, and replay context for Mayne Pharma Group Ltd..
Alternate listings
MYX:ASX
AU · AUD
Alternate listing for Mayne Pharma Group Ltd.; the primary context on this page is A1C821:LSX.
MAYNF:OTC
US · USD
Alternate listing for Mayne Pharma Group Ltd.; the primary context on this page is A1C821:LSX.
HG6:FWB
DE · EUR
Alternate listing for Mayne Pharma Group Ltd.; the primary context on this page is A1C821:LSX.
A1C821:LS
DE · EUR
Alternate listing for Mayne Pharma Group Ltd.; the primary context on this page is A1C821:LSX.